clientcongress.com

SEPTEMBER 21 – 23, 2020

1:30 PM EST

MONDAY, SEPT. 21

1:00 PM EST

Keith Dunleavy, M.D., Chief Executive Officer and

Chairman of the Board, Inovalon

Scott Gottlieb, M.D., 23rd Commissioner of Food

and Drug Administration

KEYNOTE ADDRESS

Welcome to Inovalon Client Congress 2020

Dr. Gottlieb is a physician, medical policy expert and public health advocate who served as the 23rd Commissioner of the U.S. Food and Drug Administration. Hear his expert commentary regarding advancing public health, promoting data-driven approaches to improving outcomes, reshaping healthcare delivery and expanding consumer choice and safety.

Dr. Gottlieb frequently appears before Congress and is a regular guest on CNBC, Face the Nation, CBS News and Fox News and is regularly featured in media outlets such as Health Affairs, The Wall Street Journal, The Washington Post, and The New York Times.

KEYNOTE ADDRESS

Sarah Butler, Head of Sales, Marketing, and Operations, Avalere

Matt Kazan, Principal, Avalere

Elizabeth Carpenter, Head of Advisory Services,

Avalere

1:00 PM EST

1:45 PM EST

Companies that anticipate and adjust early to the inevitable changes coming in our healthcare system will be at the forefront of reform. Hear from our panel of senior executives who are creating practical strategies to answer these necessary questions: Where are healthcare organizations betting their operating and capital resources for the future? Will coverage meaningfully change as a result of COVID-19 and increased awareness of health disparities? How will information technology evolve to drive commercial operations? Where will the shift to value take us in the plan, provider, and life sciences sectors over the coming 5 years?

Pat Wang, CEO, Healthfirst

Rob Santilli, CEO, Gunnison Valley Health

System

Moderated by Dan Mendelson, Fellow, Advisory Strategy,

Inovalon; Founder and former CEO, Avalere

Murdo Gordon, EVP, Global Commercial

Operations, Amgen

The ongoing COVID-19 pandemic and the presidential election are just two critical elements that will shape the future of our healthcare system in the coming years. To effectively navigate these and other pivotal changes, healthcare leaders need to prepare their organizations for short- and long-term industry shifts. In this session, industry experts will discuss the key market changes that will affect plans, providers and operators in 2021 and beyond.

COVID-19, HEALTHCARE DISPARITIES, AND THE SHIFT TO VALUE: HOW TO LEAD CHANGE VERSUS FOLLOWING

THE THREE FUTURES: HOW COVID-19 AND THE ELECTION WILL CHANGE HEALTHCARE

TUESDAY, SEPT. 22

KEYNOTE

KEYNOTE

Bill Carden, Senior Director, Quality

Spectrum, Inovalon

Laura Hart, Principal & CEO, Attest Health Care Advisors

David R. Nerenz, Ph.D., Director Emeritus, Center

for Health Policy and Health Services Research, Henry Ford

Health System

Tina Kind, Principal, DTS Group

1:00 PM EST

2:30 PM EST

Social determinants of health (SDOH) have a powerful impact on healthcare outcomes, utilization and economics. In this session, get a multi-stakeholder perspective from some of the industry’s leading SDOH experts representing payers, policy experts and economists as they explore new and innovative data-driven approaches to advancing the use of SDOH data to improve quality outcomes and reduce disparities.

In this highly anticipated session, join veteran auditors as they provide the latest insights into the upcoming HEDIS® quality measurement and reporting season through the lens of the COVID-19 public health emergency. Learn what’s changing, what to expect and how you can ensure your health plan is best prepared to adapt its quality measurement program in this unprecedented, evolving environment.

Moderated by Christie Teigland, Ph.D., Principal,

Health Economics & Advanced Analytics, Avalere

Philip M. Alberti, Ph.D., Senior Director, Health Equity

Research and Policy, Association of American Medical Colleges

DATA-DRIVEN STRATEGIES LEVERAGING SOCIAL DETERMINANTS OF HEALTH DATA TO IMPROVE QUALITY

OUTCOMES AND ECONOMICS

AUDITOR PANEL

WEDNESDAY, SEPT. 23

TRACK SESSION

KEYNOTE

Moderated by Eric Sullivan, Senior Vice President, Innovation

& Data Strategies, Inovalon

Mariann Yeager, Chief Executive Officer,

The Sequoia Project

Fred Bentley, Managing Director, Avalere

1:45 PM EST

Efforts to establish interoperability and enable standardized, real-time data exchange across the healthcare industry are accelerating as a result of new regulatory requirements aimed at promoting data transparency and patient access to their own health information – fundamentally changing the way health plans do business. Join our industry experts from across the care continuum as they examine the impact of federal rules like TEFCA and the CMS/ONC Interoperability Rule on driving connectivity and interoperability in healthcare, provide insight into how health plans are preparing for upcoming API requirements, and explore innovative strategies and solutions helping health plans thrive in the new era of interoperability.

THE NEW ERA OF INTEROPERABILITY: IMPROVING PATIENT ENGAGEMENT AND OUTCOMES VIA REAL-TIME HEALTH DATA ACCESS

2:30 PM EST

Successfully engaging members requires innovative strategies to support greater quality outcomes for a health plan. This can be challenging given the diversity of membership, niche populations and demographics that vary significantly. These challenges coupled with a global pandemic have increased the need to engage members to ensure continuity of care and wellness initiatives for accurate reflection of risk scores.

In this session, gain insight into the importance of flexible engagement strategies to overcome barriers to care and learn how broadening the focus to encompass the full member experience can not only also improve the health of your member populations but also enables improved performance on quality measures.

Jim Clement, Vice President,

Product & Services, Inovalon

Zachary Clark, MBA MPH, Senior

Vice President, Business

Development, BioIQ

Nader Hawit, Senior Director,

Product Management,

Inovalon

Catherine Macpherson, MS, RDN, Vice President, Product

Strategy and Development and Chief Nutrition Officer,

MOM’S Meals

IMPROVING THE MEMBER EXPERIENCE (MEETING THE MEMBER WHERE THEY ARE)

KEYNOTE

TRACK SESSION

Kelley McChesney, Senior Director, Product

Execution, Inovalon

The onset of the COVID-19 pandemic created quality measurement challenges that have required regulators to shift their focus and approach. In this session, attendees will gain perspective on how the quality measurement environment was evolving prior to the COVID-19 pandemic and how health plans should be prepared for changes. Our expert panelists will share insight into the feature direction of NCQA regulations, health plan performance, delivery of quality care, and how clinical data exchange can be leveraged in today’s climate to drive improved quality outcomes.

Courtney Breece, Senior Director, Product Management, Inovalon

Mary Barton, M.D., Vice President, Performance

Measurement, NCQA

REGULATORY UPDATE: NCQA + CLINICAL DATA EXCHANGE

The final CMS/ONC Interoperability Rule released earlier this year implements certain provisions of the 21st Century Cures Act, including requirements for health plans to enable healthcare consumers to easily access their personal health data and provider-level information. Health plans are now on an accelerated path toward FHIR®-based real-time clinical data exchange. What are the different approaches, best practices and unforeseen challenges we’re seeing as we move toward the first deadline in 2021? Find out from industry, policy and health plan experts in this informative session.

Henry Archibong, Associate Vice President,

Interoperability Solutions, Inovalon

Fred Bentley, Managing Director, Avalere

A DEEP DIVE INTO THE INTEROPERABILITY FINAL RULE & UPCOMING MANDATES

ON-DEMAND TRACK SESSIONS

Predictive analytics is about using past data and information to predict the likelihood of a future event or outcome for an individual or group of individuals. This concept isn’t a new phenomenon in healthcare, and yet, adoption of predictive analytics to improve population health management and drive improvements in health outcomes is not widely leveraged. To date, the healthcare industry has fallen short of maturing its predictive analytics capabilities to be an engine that powers population health management. In this session, you will learn how about Inovalon’s next generation predictive analytic capabilities and how they are currently being used to enable more accurate, reliable clinical decision making and population health management.

The data generated in the healthcare industry increases by 48 percent every year, making it an ongoing challenge for healthcare organizations to ensure they can quickly access the data they need to make strategic decisions that impact their business and – most importantly – healthcare consumers. In this session, hear from healthcare data experts about the innovative ways health plans are leveraging data lakes beyond their use as a healthcare data repository, to address and guide decisions on strategic initiatives around their quality, risk score accuracy and care management programs, business operations, provider network improvement, and more.

Rhondee Baldi, M.D., Senior Medical Director,

Inovalon

Eric Sullivan, Senior Vice President, Innovation &

Data Strategies, Inovalon

Arati Swadi, Senior Director, Product

Execution, Inovalon

Oliver Ha, Senior Business Systems

Analyst, Inovalon

Michael Lutz, Senior Consultant, Avalere

USE OF PREDICTIVE ANALYTICS TO EMPOWER POPULATION INSIGHTS

BUILDING A BETTER DATA LAKE: FROM 360° PATIENT PROFILES TO STRATEGIC BUSINESS INSIGHTS

ON-DEMAND TRACK SESSIONS

ON-DEMAND TRACK SESSIONS

Quality measurement, reporting and improvement is continuously transforming, from the introduction of digital measures to improved EHR interoperability to new strategies – all with the goal of driving greater member engagement. Join us as our experts discuss the evolution of the quality healthcare landscape, how new, innovative technological advancements are helping reduce the burden of quality measurement and reporting, and Inovalon ONE® Platform updates and enhancements on the horizon that will further improve your experience and quality performance.

The healthcare ecosystem lacks the robust connectivity needed between stakeholders to provide a holistic view of patients’ total health. The impact of this deficit is experienced acutely among patients who are prescribed high-cost, high-touch medications that are provided to them through specialty pharmacies. As one of the fastest growing capabilities to standardize the exchange of healthcare data and information, HL7® FHIR® is providing greater opportunities for patient data and information sharing, enabling a more complete view of a patient’s total health and care journey. In this session, you will learn how specialty pharmacies supported by ScriptMed® Cloud are leveraging FHIR®-enabled healthcare data exchange to achieve near real-time visibility into a patient’s health profile through data supplementation. You will gain insight into how cloud-based technology and FHIR®-delivered supplemental data are supporting holistic clinical quality management of patients and their conditions as they manage the complicated nature of their diagnoses and medication needs.

Courtney Breece, Senior Director, Product Management, Inovalon

Kate Eshelman, M.D., VP, Medical Informatics,

Inovalon

Hemanth Doma, Senior Director, Product Management, Inovalon

Rick Miller, RPh, VP, Clinical and Professional

Services, AllianceRx Walgreens Prime

NAVIGATING THE FUTURE OF QUALITY

LEVERAGING FHIR®-ENABLED DATA SUPPLEMENTATION TO ENHANCE PATIENT OUTCOMES AND THE EXPERIENCE OF CARE:

A SPOTLIGHT ON SPECIALTY PHARMACY